Improving medication adherence for patients with metastatic breast cancer
Official title: Optimizing an Intervention to Increase Oral Medication Adherence for Metastatic Breast Cancer Patients
Run by European Institute of Oncology · NCT06726889 · Data updated 2026-11-12
This study is testing a new way to help people with metastatic breast cancer remember to take their oral medications by using personalized reminders and feedback.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 104 (estimated) |
| Sponsor | European Institute of Oncology Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | January 25, 2024 |
| Main results expected | April 2025 |
| Study ends | April 2025 |
| Registry record updated | December 20, 2024 |
| Trial ID | NCT06726889 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old diagnosed with metastatic breast cancer who are prescribed oral anticancer agents and have access to a smartphone with internet.
✕Probably not a fit
Patients with psychiatric disorders or other comorbidities that may impair their ability to comply with study procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance adherence to oral anticancer medications among patients with metastatic breast cancer by optimizing an intervention that combines informative documentation, personalized reminders, and feedback. Utilizing a full factorial design, the study will evaluate the effectiveness of these components in promoting medication adherence. The focus is on patients who prefer oral medication due to its convenience, addressing the common issue of non-adherence in this population. By tailoring the intervention to the specific needs of metastatic breast cancer patients, the study seeks to improve treatment outcomes.
Why it matters
Potential benefit: If successful, this study could significantly improve medication adherence, leading to better treatment outcomes for patients with metastatic breast cancer.
How similar studies have gone: While there have been various interventions aimed at improving adherence in early-stage breast cancer patients, this approach specifically targeting metastatic breast cancer patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a diagnosis of metastatic BC * Patients with a prescription for any OAA (i.e. oral chemotherapy, endocrine therapy, and Cyclin-Dependent Kinase 4/6 Inhibitors) * Age \>18 years old * Patients with a personal smart phone with internet access * Willingness and ability to comply with scheduled visits and other trial procedures * Understanding and speaking Italian language * Written informed consent Exclusion Criteria: * Psychiatric disorders or conditions that might impair the ability to give informed consent * Comorbidity that may impact on compliance to study procedures
Where it's running
-
European Institute of Oncology
Milan, Italy Recruiting
Study contacts
- Principal investigator: Gabriella Pravettoni, MD — European Istitute of Oncology
- Study coordinator: Gabriella Pravettoni, MD
- Email: gabriella.pravettoni@ieo.it
- Phone: +39 0257489731
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.